ENO2 and neoplasm: Results showed elevated levels of tumor markers, including serum neuron-specific enolase (NSE) (55.0 ng/mL), urinary vanillylmandelic acid (15.5 μg/mg/creatinine), and urinary homovanillic acid (48.3 μg/mg/creatinine).